Smallwood Wealth Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Smallwood Wealth Investment Management’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Hold	8,000	–	–	0.11%	84
2026 Q1	$198K	Hold	8,000	–	–	0.1%	79
2025 Q4	$187K	Hold	8,000	–	–	0.1%	86
2025 Q3	$158K	Hold	8,000	–	–	0.08%	96
2025 Q2	$174K	Buy	8,000 +500	+7%	+$11.8K	0.1%	82
2025 Q1	$182K	Buy	+7,500	New	+$169K	0.11%	82

Other funds holding CPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CIEC

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

CWP

Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Smallwood Wealth Investment Management's CPRX Position: Q2 2026 in Review

Smallwood Wealth Investment Management held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 8,000 shares worth $251K. The position accounts for 0.11% of the portfolio, ranked #84.

Smallwood Wealth Investment Management first reported a position in CPRX in Q1 2025 and has held it in 6 quarters since. 112 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Smallwood Wealth Investment Management held 8,000 shares of Catalyst Pharmaceutical worth $251K as of Q2 2026.
Smallwood Wealth Investment Management left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
Catalyst Pharmaceutical made up 0.11% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #84 holding.
Smallwood Wealth Investment Management first reported a position in Catalyst Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
112 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.